curasan AG
curasan publishes annual report and details of outlook
DGAP-News: curasan AG / Key word(s): Final Results – Gross sales revenues for the full year 2016 rise by 16.1 percent to EUR 6.9 million – EBITDA at EUR -2.1 million below the previous year’s figure, which was influenced by special effects – Equity slightly increased to EUR 8.9 million – Break even expected as of 2018
Adjusted sales revenues for the full year 2016 rose by 16.1 percent to EUR 6.9 million (2015: EUR 5.9 million). Of this, EUR 2.10 million was earned in the fourth quarter, corresponding to an increase of 36.4% over the previous year (Q4 2015: EUR 1.5 million). As previously announced, gross sales revenues for 2016 are thus in the middle of the expected range from EUR 6.7-7.1 million. However, as anticipated, large investments in sales and marketing led to declines in the results. Earnings before taxes, interest, depreciation and amortization (EBITDA) amounted to EUR -2.1 million (2015: EUR 2.1 million). Non-recurring effects resulting from the settlement of a dispute with Stryker SA had led to an income of EUR 4.5 million in the previous year. Accordingly, earnings before taxes und interest (EBIT) at EUR -2.7 million were likewise significantly below those of the previous year (2015: EUR 1.5 million). After capitalization of loss carried forward leading to a tax income of EUR 0.7 million, the deficit for the year amounted to EUR – 2.1 million, corresponding to a loss per share of EUR – 0.21. The company’s equity developed positively, rising slightly to EUR 8.95 million as the result of a capital increase carried out in December. The equity ratio at the end of the year was 70.9%, compared to 70.3% as of the reference date in the previous year. Liquidity at 31 December 2016 declined slightly to EUR 1.0 million (2015: EUR 1.6 million). “In 2016, we experienced significant growth and are now receiving better market feedback on our products month after month,” said Michael Schlenk, CEO of curasan AG, in his comments on the figures. “In 2017 we will continue to benefit from our investments in marketing and sales. In 2018 we will then be in a position to profit from our current efforts and curasan will be able to reach break-even.” The management board of curasan AG expects continuing dynamic business performance in fiscal year 2017. Based on the internal budget planning process and the expectations of external sales partners, the company thus anticipates gross sales revenues between EUR 8.5-8.8 million. Bearing in mind the current strong growth, curasan is planning to utilize this momentum and increase its investments in sales growth to acquire additional market shares in Asia and particularly in the United States in 2017. The management board therefore expects a target figure between EUR -1.6 and EUR – 2.0 million for the net result. The full annual report for 2016 is available for download on the company website at www.curasan.de.
About curasan AG: Contact: Ingo Middelmenne Head of Investor Relations Tel. +49 6027 40900-45 Fax +49 6027 40900-39 ingo.middelmenne@curasan.de Andrea Weidner Head of Corporate Communications Tel. +49 6027 40900-51 Fax +49 6027 40900-39 andrea.weidner@curasan.de www.curasan.de
27.04.2017 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |
Language: | English |
Company: | curasan AG |
Lindigstraße 4 | |
63801 Kleinostheim | |
Germany | |
Phone: | 06027/40 900 0 |
Fax: | 06027/40 900 29 |
E-mail: | info@curasan.de |
Internet: | www.curasan.de |
ISIN: | DE0005494538 |
WKN: | 549453 |
Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
End of News | DGAP News Service |